Showing results (91-100 of 183) with videos related to

Sort By:
Pageof 19
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2021
What's behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patternsJan H Rüschoff, Daniela A Ferraro, Urs J Muehlematter, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|April 29, 2020
Diagnostic Accuracy of PET/CT and Contrast Enhanced CT in Patients With Suspected Infected Aortic AneurysmsLars Husmann, Martin W Huellner, Bruno Ledergerber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2025
High-Intensity Focused Ultrasound in Prostate Cancer: Can PSMA PET Improve Focal Therapy Outcomes?Alexander Maurer, Urs J Muehlematter, Thibika Sivakumar, et al.
Scientific Reports|March 4, 2021
PET/CT in therapy control of infective native aortic aneurysmsLars Husmann, Martin W Huellner, Nadia Eberhard, et al.
Head and Neck Pathology|May 13, 2022
Immunohistochemical Expression Pattern of Theragnostic Targets SSTR2 and PSMA in Endolymphatic Sac Tumors: A Single Institution Case SeriesMuriel D Brada, Elisabeth J Rushing, David Bächinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2013
Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detectionCaecilia S Reiner, Paul Stolzmann, Lars Husmann, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial resultsMoritz Schwyzer, Daniela A Ferraro, Urs J Muehlematter, et al.
Life (Basel, Switzerland)|September 28, 2021
When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing SarcomaRuben I Hack, Anton S Becker, Beata Bode-Lesniewska, et al.
Insights Into Imaging|April 15, 2022
Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patientsRiccardo Laudicella, Stephan Skawran, Daniela A Ferraro, et al.
Pageof 19